Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the benzothiazine class of organic compounds. It features a cyclopentyl group and a sulfonamide moiety attached to a benzothiazine core. The molecule has been identified in chemical databases as an experimental or candidate drug but does not have an established therapeutic use or approved indication. Its mechanism of action and biological targets are not described in public sources. There is no evidence it has advanced beyond early-stage research or screening[1][9][3].
- Other names
- (3R)-3-cyclopentyl-7-(4-methylpiperazin-1-ylsulfonyl)-3,4-dihydro-2H-1λ⁶,2-benzothiazine 1,1-dioneSCHEMBL21067968SCHEMBL-21067968SCHEMBL 21067968NS6NS-6NS 6
Beyond the preview
Go deeper on (3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide.